A comparative analysis of breast cancer subtypes based on cancer cell heterogeneity reveals that FABP7 may act as a tumor suppressor, holding significant clinical implications for diagnosis, prognosis, and targeted therapy in breast cancer patients[148]. This evidence concerns the gene FABP7 and breast cancer.